The chemical class of ATPBD1B Activators encompasses compounds that are specifically engineered to increase the activity of the protein encoded by the ATPBD1B gene, which is presumed to be involved in cellular processes that utilize ATP, the primary energy currency of the cell. The term ATPBD suggests that the protein has an ATP-binding domain, crucial for its function, and activators in this class would thus be designed to bind to this domain, potentially enhancing the protein's ATP-binding affinity or stabilizing the protein in an active state. To pinpoint these activators, researchers rely on an understanding of the protein's three-dimensional structure and the mechanics of its interaction with ATP. This might involve computational methods to predict the protein's structure, especially the ATP-binding domain, and experimental validation using techniques like site-directed mutagenesis and biophysical assays to elucidate the effects of potential activators on the protein's function.
The discovery process for ATPBD1B Activators would likely involve high-throughput screening to test large compound libraries for molecules that can modulate the protein's activity, with hits undergoing subsequent rounds of optimization to improve their specificity and efficacy. Such optimization would be informed by detailed structural analyses, possibly using crystallography or NMR to understand how these molecules interact with the ATPBD1B protein at the molecular level. Alongside structural studies, biochemical assays would play a crucial role in characterizing the effects of potential activators on ATPBD1B's activity, such as measuring changes in ATP hydrolysis rates or alterations in protein conformation. These efforts would collectively contribute to a deeper knowledge of ATPBD1B's role within cellular biochemistry by providing tools to manipulate its activity in a controlled manner, with the objective of studying its function and regulatory mechanisms independently of any medical context or application.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin stimulates cAMP production and activates PKA, which could enhance GPN2 expression through cAMP response element-binding (CREB) proteins. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), which could lead to upregulation of GPN2 expression as part of a cellular response to activated PKC signaling. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $30.00 $60.00 $93.00 | 27 | |
H2O2 is a reactive oxygen species that can induce oxidative stress response genes, potentially including GPN2 as a protective mechanism. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Insulin signaling affects a wide range of cellular processes and could potentially induce GPN2 expression as part of metabolic regulation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid affects gene expression and differentiation and might modulate GPN2 expression in a context-dependent manner. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
LiCl inhibits glycogen synthase kinase-3 (GSK-3) and may influence GPN2 expression through Wnt signaling pathways. |